aerospace · stock-sale · portfolio-rebalancing
Rep. Kevin Hern Dumps Aerospace Spin-Off HONA Ahead of 11% Slide
The Oklahoma Republican sold his newly acquired Honeywell Aerospace shares as part of a multi-ticker portfolio cleanup.
2026-09-10 — Kevin Hern · HONA
Key facts
- Rep. Kevin Hern sold between $15,001 and $50,000 of Honeywell Aerospace (HONA) on August 19, 2026.
- The newly spun-off stock fell roughly 11% from the sale price in the weeks following the transaction.
- The trade was part of a larger cluster of five sales executed by Hern over a two-day window, indicating broad portfolio rebalancing.
- A corporate director purchased 6,400 shares of HONA on the open market the same day Hern disclosed his sale.
Rep. Kevin Hern (R-Okla.) recently parted ways with a newly minted piece of the defense and aerospace sector. On August 19, Hern sold between $15,001 and $50,000 of Honeywell Aerospace Inc. (HONA), just weeks after the company completed its spin-off from Honeywell International and began trading independently.
The timing proved highly advantageous. Following Hern’s sale, the aerospace supplier's stock slid roughly 11% from his transaction price of $170.37.
However, our analysis scored the transaction a quiet 30 out of 100, pointing to a routine portfolio cleanup rather than an informed trade. Under the STOCK Act, members of Congress are required to disclose their financial transactions within 45 days, and transactions are reported in broad ranges rather than exact amounts. Hern disclosed the transaction on September 1, representing a brief 13-day filing lag.
Hern had never previously traded HONA. Because the company was spun off on June 29, 2026, it is highly likely Hern automatically received these shares as a legacy holder of parent company Honeywell. Investors frequently sweep away small, automatically acquired spin-off positions to keep their portfolios concentrated on core holdings.
The broader context of Hern's trading window supports this administrative explanation. On the same day as the HONA sale, Hern sold shares of Colgate-Palmolive. The day prior, on August 18, he executed sales of Biogen, Kimberly-Clark, and Anheuser-Busch InBev. This multi-ticker cluster across completely unrelated sectors strongly points to a general cash-generation or rebalancing event rather than a targeted play on aerospace.
Furthermore, any negative fundamental outlook was already public. Honeywell Aerospace had revised its full-year guidance downward on August 5 due to supply constraints. If Hern was reacting to bad news, he did so with a two-week lag on fully public information.
Hern serves on the House Committee on Ways and Means, which holds tangential jurisdiction over international trade and tariffs. But the committee has no direct legislative or budgetary authority over aerospace procurement or FAA regulations.
Corporate insiders also seem to disagree with the member's exit. On September 1, the same day Hern filed his disclosure, Honeywell Aerospace director Craig Arnold purchased 6,400 shares on the open market at $156.00.
Sometimes, a timely exit is just the byproduct of taking out the portfolio trash.
Sources
- Honeywell Aerospace Spin-off Completion 8-K — SEC EDGAR
- Honeywell Aerospace Q2 2026 Earnings and Outlook 8-K — SEC EDGAR
- Craig Arnold SEC Form 4 Insider Purchase — SEC EDGAR